Home›Stock Screener›Fermenta Biotech›Quarterly Results

Fermenta Biotech Quarterly Results

Latest Quarter Net Profit
₹19 Cr
QMar 2026
Quarterly Results

Fermenta Biotech quarterly results. In Mar 2026, Fermenta Biotech (FERMENTA) reported revenue ₹136 Cr and net profit ₹19 Cr — revenue -5.6% YoY. For annual financials, live price and key ratios, visit FERMENTA screener.

FERMENTA Quarterly Results — Revenue, Profit & EPS Highlights

Fermenta Biotech latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review FERMENTA PE ratio trends to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹136 Cr in Mar 2026 (+7.9% vs Jun 2026, -5.6% vs Mar 2025)
  • Net Profit of ₹19 Cr in Mar 2026 (+90.0% vs Jun 2026, -42.4% vs Mar 2025)
  • EBITDA of ₹34 Cr in Mar 2026 (+54.5% vs Jun 2026)
  • Operating Margin of 16.0% in Mar 2026 (+1.0pp vs Jun 2026)
  • Earnings Per Share of ₹6.66 in Mar 2026 (+95.9% vs Jun 2026)

Fermenta Biotech Quarterly Results — Revenue, EBITDA, Net Profit & EPS

FERMENTA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 136 126 136 144 145 7.9% -5.6%
Net Profit (₹ Cr) 19 10 18 33 22 - -
EBITDA (₹ Cr) 34 22 32 41 37 - -
EPS (₹) 6.66 3.40 6.20 11.79 7.49 - -
Operating Margin (%) 16.0% 15.0% 20.0% 26.0% 21.0% - -

FERMENTA Share Price Trend — 1-Year Movement Across Quarterly Results

Fermenta Biotech 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Fermenta Biotech marketcap in USD to track the company's total market size over time.

Profitability Ratios

Profit Margin 14.0%
EBITDA Margin 25.0%
Operating Margin 16.0%
ROE (Annual) 19.0%

Balance Sheet Highlights

Total Assets ₹648 Cr
Total Equity ₹401 Cr
Current Assets ₹388 Cr
Current Liabilities ₹39 Cr

Cash Flow Analysis

Operating Cash Flow ₹93 Cr
Investing Cash Flow ₹-43 Cr
Financing Cash Flow ₹-42 Cr
Net Cash Flow ₹8 Cr

Current Market Data

Current Price ₹557.45
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 144
Sept 2025 136
Jun 2026 126
Mar 2026 136

Net Profit Trend (₹ Cr)

Mar 2025 33
Sept 2025 18
Jun 2026 10
Mar 2026 19

Operating Margin Trend (%)

Mar 2025 26.0%
Sept 2025 20.0%
Jun 2026 15.0%
Mar 2026 16.0%

FERMENTA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Fermenta Biotech latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Laurus Labs
Mar 2026 		₹109,629.35 Cr 1971.4 1,823 282 -10.5% - 15.5% 381.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores